Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Peracute onset of severe tumor lysis syndrome immediately after 4 Gy fractionated TBI as part of reduced intensity preparative regimen in a patient with T-ALL with high tumor burden

Summary:

We report a 30-year-old patient with therapy-refractory T-ALL undergoing unrelated allogeneic PBSCT. He developed severe tumor lysis syndrome (TLS) with extreme biochemical changes, cardiac and neurological symptoms and dialysis-dependent acute renal failure after TBI (4 Gy) on the first day of reduced intensity conditioning (RIC) for unrelated allogeneic PBSCT. The patient's clinical condition was stabilized after beginning daily hemodialysis and treatment for disturbed electrolytes, metabolic acidosis and plasma coagulation, as well as reduction of uric acid by rasburicase. The conditioning therapy and the allogenic PBSCT were scheduled according to the preparative regimen. According to our knowledge, severe TLS induced by 4 Gy TBI has not been reported so far. Regimen-related toxicity using RIC regimen was mild, allowing 30–50% of the patients to have an entirely outpatient transplantation. However, we would like to point out that severe TLS could also complicate PBSCT using RIC regimens in patients with relatively radiation-sensitive malignancies and high tumor burden.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Ezzone S . Tumor lysis syndrome. Semin Oncol Nurs 1999; 15: 202–208.

    Article  CAS  Google Scholar 

  2. Altmann A . Acute TLS. Semin Oncol 2001; 28 (Suppl. 5): 3–8.

    Article  Google Scholar 

  3. Sallan S . Management of acute TLS. Semin Oncol 2001; 28 (Suppl. 5): 9–12.

    Article  CAS  Google Scholar 

  4. Fleming DR, Doukas M . Acute TLS in hematologic malignancies. Leuk Lymphoma 1992; 8: 315–318.

    Article  CAS  Google Scholar 

  5. Razis E, Arlin Z, Ahmed T et al. Incidence and treatment of TLS in patients with acute leukemia. Acta Haematol 1994; 91: 171–174.

    Article  CAS  Google Scholar 

  6. Nomdedeu J, Martino R, Sureda A et al. Acute tumor lysis syndrome complicating therapy for bone marrow transplantation in a patient with chronic lymphocytic leukemia. Bone Marrow Transplant 1994; 13: 659–660.

    CAS  PubMed  Google Scholar 

  7. Fleming DR, Henslee-Downey PJ, Coffey CW . Radiation-induced acute tumor lysis syndrome in the bone marrow transplant setting. Bone Marrow Transplant 1991; 8: 235–236.

    CAS  PubMed  Google Scholar 

  8. Lerza R, Botta M, Barsotti B et al. Dexamethasone-induced acute tumor lysis syndrome in a T-cell malignant lymphoma. Leuk Lymphoma 2002; 43: 1129–1132.

    Article  CAS  Google Scholar 

  9. Feinstin L, Storb R . Reducing transplant toxicity. Curr Opin Hematol 2001; 8: 342–348.

    Article  Google Scholar 

  10. Mc Sweeney PA, Niederwieser D, Shizuru JA et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390–3400.

    Article  CAS  Google Scholar 

  11. Nagler A, Slavin S, Varadi G et al. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma. Bone Marrow Transplant 2000; 25: 1021–1028.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Linck, D., Basara, N., Tran, V. et al. Peracute onset of severe tumor lysis syndrome immediately after 4 Gy fractionated TBI as part of reduced intensity preparative regimen in a patient with T-ALL with high tumor burden. Bone Marrow Transplant 31, 935–937 (2003). https://doi.org/10.1038/sj.bmt.1704025

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704025

Keywords

Search

Quick links